AGP Executive Report
Last update: 5 hours agoBiotech Watch: Molecular Partners says it has dosed first patients in a Phase 2 TACTIC trial of MP0317 for advanced cholangiocarcinoma, with nine sites recruiting in France and results due in 2027. Luxury & Markets: Richemont kicked off fiscal 2027 with Q1 sales up 20% at constant exchange rates, led by a 24% jump in jewellery, lifting Swiss stocks as the sector keeps surprising analysts. Trade & Business: Switzerland and the UK have concluded an enhanced free trade deal, including big services improvements and new access for UK food exports like beef, lamb and dairy. Regulation: Switzerland’s Federal Court upheld Valais’ ban on disposable e-cigarettes, backing the canton’s public health and environmental rationale. Politics & Society: A Swiss bishop revoked SSPX permissions to use diocesan churches after consecrations without papal mandate. Environment & Health: Basel’s little-owl conservation project won the Walder Prize after helping the species return to breeding in the region. Geneva Activism: Kurdish community activists held another “Freedom Vigil” at the UN, renewing calls for Abdullah Öcalan’s release.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
